Differential plasma glycoproteome of p19ARF skin cancer mouse model using the Corra label-free LC-MS proteomics platform

被引：8

作者：

Letarte S. ^{[1
]}

Brusniak M.-Y. ^{[1
]}

Campbell D. ^{[1
]}

Eddes J. ^{[1
]}

Kemp C.J. ^{[2
]}

Lau H. ^{[1
]}

Mueller L. ^{[3
]}

Schmidt A. ^{[3
,4
]}

Shannon P. ^{[1
]}

Kelly-Spratt K.S. ^{[2
]}

Vitek O. ^{[1
]}

Zhang H. ^{[5
]}

Aebersold R. ^{[1
,3
,4
,6
]}

Watts J.D. ^{[1
]}

机构：

[1] Institute for Systems Biology, Seattle, WA 98103

[2] Fred Hutchinson Cancer Research Center, Seattle, WA 98109

[3] Institute for Molecular Systems Biology, ETH-Zurich

[4] Competence Center for Systems Physiology and Metabolic Diseases, ETH Zurich

[5] Department of Pathology, Johns Hopkins University, Baltimore

[6] Faculty of Science, University of Zurich, Zurich

来源：

Clinical Proteomics | 2008年 / 4卷 / 3-4期

基金：

美国国家卫生研究院;

关键词：

Biomarker discovery; Glycoproteomics; Label-free protein quantification; LC-MS; Plasma; Skin cancer; Systems biology; Targeted peptide sequencing;

D O I：

10.1007/s12014-008-9018-8

中图分类号：

学科分类号：

摘要：

Introduction: A proof-of-concept demonstration of the use of label-free quantitative glycoproteomics for biomarker discovery workflow is presented in this paper, using a mouse model for skin cancer as an example. Materials and Methods: Blood plasma was collected from ten control mice and ten mice having a mutation in the p19ARF gene, conferring them high propensity to develop skin cancer after carcinogen exposure. We enriched for N-glycosylated plasma proteins, ultimately generating deglycosylated forms of the tryptic peptides for liquid chromatography mass spectrometry (LC-MS) analyses. LC-MS runs for each sample were then performed with a view to identifying proteins that were differentially abundant between the two mouse populations. We then used a recently developed computational framework, Corra, to perform peak picking and alignment, and to compute the statistical significance of any observed changes in individual peptide abundances. Once determined, the most discriminating peptide features were then fragmented and identified by tandem mass spectrometry with the use of inclusion lists. Results and Discussions: We assessed the identified proteins to see if there were sets of proteins indicative of specific biological processes that correlate with the presence of disease, and specifically cancer, according to their functional annotations. As expected for such sick animals, many of the proteins identified were related to host immune response. However, a significant number of proteins are also directly associated with processes linked to cancer development, including proteins related to the cell cycle, localization, transport, and cell death. Additional analysis of the same samples in profiling mode, and in triplicate, confirmed that replicate MS analysis of the same plasma sample generated less variation than that observed between plasma samples from different individuals, demonstrating that the reproducibility of the LC-MS platform was sufficient for this application. Conclusion: These results thus show that an LC-MS-based workflow can be a useful tool for the generation of candidate proteins of interest as part of a disease biomarker discovery effort. © 2008 Humana Press.

引用

页码：105 / 116

页数：11

共 46 条

[21] Zhang H., Loriaux P., Eng J., Campbell D., Et al., UniPep-a database for human N-linked glycosites: A resource for biomarker discovery, Genome Biol, 7, (2006)
[22] Gygi S.P., Rist B., Gerber S.A., Turecek F., Et al., Quantitative analysis of complex protein mixtures using isotope-coded affinity tags, Nat Biotechnol, 17, pp. 994-999, (1999)
[23] Ong S.-E., Blagoev B., Kratchmarova I., Kristensen D.B., Et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics, Mol Cell Proteomics, 1, pp. 376-386, (2002)
[24] Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Et al., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents, Mol Cell Proteomics, 2, pp. 1154-1169, (2004)
[25] Conrads T.P., Alving K., Veenstra T.D., Belov M.E., Et al., Quantitative analysis of bacterial and mammalian proteomes using a combination of cysteine affinity tags and 15N metabolic labeling, Anal Chem, 73, pp. 2132-2139, (2001)
[26] Veenstra T.D., Martinovic S., Anderson G.A., Pasa-Tolic L., Smith R.D., Proteome analysis using selective incorporation of isotopically labeled amino acids, J Am Soc Mass Spectrom, 11, pp. 78-82, (2000)
[27] Zhou H., Ranish J.A., Watts J.D., Quantitative proteome analysis by solid-phase isotope tagging and mass spectrometry, Nat Biotechnol, 19, pp. 512-515, (2002)
[28] Finney G.L., Blackler A.R., Hoopmann M.R., Canterbury J.D., Et al., Label-free comparative analysis of proteomics mixtures using chromatographic alignment of high-resolution muLC-MS data, Anal Chem, 80, pp. 961-971, (2008)
[29] Schmidt A., Gehlenborg N., Bodenmiller B., Mueller L., Et al., An integrated, directed mass spectrometric approach for in-depth characterization of complex peptide mixtures, Mol Cell Proteomics, (2008)
[30] Li X.-J., Yi E.C., Kemp C.J., Zhang H., Aebersold R., A software suite for the generation and comparison of peptide arrays from sets of data collected by liquid chromatography-mass spectrometry, Mol Cell Proteomics, 4, pp. 1328-1340, (2005)

← 1 2 3 4 5 →